Explore TissuePro, the latest bioprinter from TissueLabs, designed for regenerative medicine and advanced drug development.

AV Access Study to be Presented at the Vascular Annual Meeting (VAM25)DURHAM, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company ...

By 2025, it is estimated that the worldwide period orthobiologics market will have an estimate of around USD 6,414.4 million.

The sports medicine market is expected to reach approximately USD 1,300.0 million in 2025 and expand to around USD 2,317.6 million by 2035, reflecting a compound annual growth rate (CAGR) of 6.0% over ...